Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Pharmacological Implications of Flavopiridol: An Updated Overview
Hemant Joshi, Hardeep Singh Tuli, Anuj Ranjan, et al.
Molecules (2023) Vol. 28, Iss. 22, pp. 7530-7530
Open Access | Times Cited: 12

Showing 12 citing articles:

Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer
Julia S. Hillmann, Nicolaì Maass, Dirk Bauerschlag, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Antitumor activity of celecoxib with docetaxel on human triple-negative breast cancer cells
Oktay Ajikanari, Elham Miaadi, Mohaddeseh Hedayat, et al.
Gene Reports (2025), pp. 102141-102141
Closed Access
Mechanistic Insight of Pharmacological Aspects of Violacein: Recent Trends and Advancements
Abhishek Chauhan, Darin Mansor Mathkor, Hemant Joshi, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Open Access
Dynamics of epithelial–mesenchymal plasticity driving cancer drug resistance
Rashmi Bangarh, Reena V. Saini, Adesh K. Saini, et al.
Cancer Pathogenesis and Therapy (2024)
Open Access | Times Cited: 2
Exploring the expanding universe of host-virus interactions mediated by viral RNA
Alfredo Castelló, Lucı́a Álvarez, Wael Kamel, et al.
Molecular Cell (2024) Vol. 84, Iss. 19, pp. 3706-3721
Open Access | Times Cited: 2
Synthesis, structure analysis, Hirshfeld surface studies, molecular docking studies against cyclin-dependent kinases (CDKs) of sulfonamide decorated N6-benzyl aminopurines for cancer treatment
Sivakrishna Narra, Munirathinam Nethaji
Results in Chemistry (2024) Vol. 8, pp. 101592-101592
Open Access | Times Cited: 1
Identification of potential therapeutic targets for systemic lupus erythematosus based on GEO database analysis and Mendelian randomization analysis
Aishanjiang Apaer, Yanyan Shi, Alimijiang Aobulitalifu, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs): bench to bedside.
Ali Hassanzadeh, Navid Shomali, Amin Kamrani, et al.
PubMed (2024) Vol. 23, pp. 862-882
Closed Access
CDK9 inhibitors for the treatment of solid tumors
Christiana Mo, Wei Ning, T. Li, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116470-116470
Closed Access
Flavopiridol inhibits adipogenesis and improves metabolic homeostasis by ameliorating adipose tissue inflammation in a diet-induced obesity model
Salil Varshney, Durgesh Kumar, Rakhi Choudhary, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117330-117330
Open Access
Flavopiridol: a promising cyclin-dependent kinase inhibitor in cancer treatment
Uttam Singh Baghel, Priyanka Kriplani, Naishal Patel, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Identification of mitoxantrone as a potent inhibitor of CDK7/Cyclin H via structure-based virtual screening and In-Vitro validation by ADP-Glo kinase assay
Tejaswi Somarowthu, Rohan R. Patekar, Sandip B. Bharate
Bioorganic Chemistry (2024) Vol. 155, pp. 108111-108111
Closed Access
Page 1

Scroll to top